Recent Finacing
Recent Raise
Biolexis employs an AI-driven MolecuLern platform plus wet‑lab validation to identify chemical entities, running a clinical-stage metabolic pipeline for obesity and diabetes with 40 discovery and 10 IND-enabling programs.
